1
|
Noone AM, Cronin KA, Altekruse SF,
Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence
and survival trends by subtype using data from the surveillance
epidemiology and end results program, 1992–2013. Cancer Epidemiol
Biomarkers Prev. 26:632–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang H, Zhang Y, Lu Y, Song J, Huang M,
Zhang J and Huang Y: The role of stearoyl-coenzyme A desaturase 1
in clear cell renal cell carcinoma. Tumour Biol. 37:479–489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Zaidi N, Lupien L, Kuemmerle NB, Kinlaw
WB, Swinnen JV and Smans K: Lipogenesis and lipolysis: The pathways
exploited by the cancer cells to acquire fatty acids. Prog Lipid
Res. 52:585–589. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ameer F, Scandiuzzi L, Hasnain S,
Kalbacher H and Zaidi N: De novo lipogenesis in health and disease.
Metabolism. 63:895–902. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Vriens K, Christen S, Parik S, Broekaert
D, Yoshinaga K, Talebi A, Dehairs J, Escalona-Noguero C, Schmieder
R, Cornfield T, et al: Evidence for an alternative fatty acid
desaturation pathway increasing cancer plasticity. Nature.
566:403–406. 2019. View Article : Google Scholar : PubMed/NCBI
|
6
|
Iwamoto H, Abe M, Yang Y, Cui D, Seki T,
Nakamura M, Hosaka K, Lim S, Wu J, He X, et al: Cancer lipid
metabolism confers antiangiogenic drug resistance. Cell Metab.
28:104–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ntambi JM: Regulation of stearoyl-CoA
desaturase by polyunsaturated fatty acids and cholesterol. J Lipid
Res. 40:1549–1558. 1999.PubMed/NCBI
|
8
|
Falvella FS, Pascale RM, Gariboldi M,
Manenti G, De Miglio MR, Simile MM, Dragani TA and Feo F:
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated
with genetic predisposition to hepatocarcinogenesis in mice and
rats. Carcinogenesis. 23:1933–1936. 2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
von Roemeling CA, Marlow LA, Pinkerton AB,
Crist A, Miller J, Tun HW, Smallridge RC and Copland JA: Aberrant
lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl
CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol
Metab. 100:E697–E709. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kim H, Rodriguez-Navas C, Kollipara RK,
Kapur P, Pedrosa I, Brugarolas J, Kittler R and Ye J: Unsaturated
fatty acids stimulate tumor growth through stabilization of
beta-catenin. Cell Rep. 13:495–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Soto-Guzman A, Navarro-Tito N,
Castro-Sanchez L, Martinez-Orozco R and Salazar EP: Oleic acid
promotes MMP-9 secretion and invasion in breast cancer cells. Clin
Exp Metastasis. 27:505–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
von Roemeling CA and Copland JA: Targeting
lipid metabolism for the treatment of anaplastic thyroid carcinoma.
Expert Opin Ther Targets. 20:159–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Igal RA: Stearoyl-CoA desaturase-1: A
novel key player in the mechanisms of cell proliferation,
programmed cell death and transformation to cancer. Carcinogenesis.
31:1509–1515. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Roongta UV, Pabalan JG, Wang X, Ryseck RP,
Fargnoli J, Henley BJ, Yang WP, Zhu J, Madireddi MT, Lawrence RM,
et al: Cancer cell dependence on unsaturated fatty acids implicates
stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer
Res. 9:1551–1561. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tosi MR, Fini G, Tinti A, Reggiani A and
Tugnoli V: Molecular characterization of human healthy and
neoplastic cerebral and renal tissues by in vitro (1)H NMR
spectroscopy (review). Int J Mol Med. 9:299–310. 2002.PubMed/NCBI
|
16
|
Tugnoli V, Reggiani A, Beghelli R,
Tomaselli V, Trinchero A and Tosi MR: Magnetic resonance
spectroscopy and high performance liquid chromatography of
neoplastic human renal tissues. Anticancer Res. 23:1541–1548.
2003.PubMed/NCBI
|
17
|
Tugnoli V, Bottura G, Fini G, Reggiani A,
Tinti A, Trinchero A and Tosi MR: 1H-NMR and 13C-NMR lipid profiles
of human renal tissues. Biopolymers. 72:86–95. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Mukherjee A, Kenny HA and Lengyel E:
Unsaturated fatty acids maintain cancer cell stemness. Cell Stem
Cell. 20:291–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Li J, Condello S, Thomes-Pepin J, Ma X,
Xia Y, Hurley TD, Matei D and Cheng JX: Lipid desaturation is a
metabolic marker and therapeutic target of ovarian cancer stem
cells. Cell Stem Cell. 20:303–314.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kawahara I, Mori T, Goto K, Fujii K,
Ohmori H, Kishi S, Fujiwara-Tani R and Kuniyasu H: Fatty acids
induce stemness in the stromal cells of a CT26 mouse tumor model.
Pathobiology. 84:237–242. 2017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Parrales A, Ranjan A and Iwakuma T:
Unsaturated fatty acids regulate stemness of ovarian cancer cells
through NF-κB. Stem Cell Investig. 4:492017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Del Río LF, Gutiérrez-Casado E,
Varela-López A and Villalba JM: Olive oil and the hallmarks of
aging. Molecules. 21:1632016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Imanikia S, Sheng M, Castro C, Griffin JL
and Taylor RC: XBP-1 remodels lipid metabolism to extend longevity.
Cell Rep. 28:581–589.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
24
|
Giacosa A, Barale R, Bavaresco L, Faliva
MA, Gerbi V, La Vecchia C, Negri E, Opizzi A, Perna S, Pezzotti M
and Rondanelli M: Mediterranean way of drinking and longevity. Crit
Rev Food Sci Nutr. 56:635–640. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Goudeau J, Bellemin S, Toselli-Mollereau
E, Shamalnasab M, Chen Y and Aguilaniu H: Fatty acid desaturation
links germ cell loss to longevity through NHR-80/HNF4 in C.
elegans. PLoS Biol. 9:e10005992011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Schaffer JE: Lipotoxicity: When tissues
overeat. Curr Opin Lipidol. 14:281–287. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Schaffer JE: Lipotoxicity: Many roads to
cell dysfunction and cell death: Introduction to a thematic review
series. J Lipid Res. 57:1327–1328. 2016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Noto A, Raffa S, De Vitis C, Roscilli G,
Malpicci D, Coluccia P, Di Napoli A, Ricci A, Giovagnoli MR,
Aurisicchio L, et al: Stearoyl-CoA desaturase-1 is a key factor for
lung cancer-initiating cells. Cell Death Dis. 4:e9472013.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Mason P, Liang B, Li L, Fremgen T, Murphy
E, Quinn A, Madden SL, Biemann HP, Wang B, Cohen A, et al: SCD1
inhibition causes cancer cell death by depleting mono-unsaturated
fatty acids. PLoS One. 7:e338232012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Hess D, Chisholm JW and Igal RA:
Inhibition of stearoylCoA desaturase activity blocks cell cycle
progression and induces programmed cell death in lung cancer cells.
PLoS One. 5:e113942010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kleene KC: Y-box proteins combine
versatile cold shock domains and arginine-rich motifs (ARMs) for
pleiotropic functions in RNA biology. Biochem J. 475:2769–2784.
2018. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lyons SM, Achorn C, Kedersha NL, Anderson
PJ and Ivanov P: YB-1 regulates tiRNA-induced stress granule
formation but not translational repression. Nucleic Acids Res.
44:6949–6960. 2016. View Article : Google Scholar : PubMed/NCBI
|
33
|
Somasekharan SP, El-Naggar A, Leprivier G,
Cheng H, Hajee S, Grunewald TGP, Zhang F, Ng T, Delattre O,
Evdokimova V, et al: YB-1 regulates stress granule formation and
tumor progression by translationally activating G3BP1. J Cell Biol.
208:913–929. 2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Willis WL, Hariharan S, David JJ and
Strauch AR: Transglutaminase-2 mediates calcium-regulated
crosslinking of the Y-Box 1 (YB-1) translation-regulatory protein
in TGFβ1-activated myofibroblasts. J Cell Biochem. 114:2753–2769.
2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhang A, Liu X, Cogan JG, Fuerst MD,
Polikandriotis JA, Kelm RJ Jr and Strauch AR: YB-1 coordinates
vascular smooth muscle α-actin gene activation by transforming
growth factor β1 and thrombin during differentiation of human
pulmonary myofibroblasts. Mol Biol Cell. 16:4931–4940. 2005.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Miao X, Wu Y, Wang Y, Zhu X, Yin H, He Y,
Li C, Liu Y, Lu X, Chen Y, et al: Y-box-binding protein-1 (YB-1)
promotes cell proliferation, adhesion and drug resistance in
diffuse large B-cell lymphoma. Exp Cell Res. 346:157–166. 2016.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Heumann A, Kaya Ö, Burdelski C, Hube-Magg
C, Kluth M, Lang DS, Simon R, Beyer B, Thederan I, Sauter G, et al:
Up regulation and nuclear translocation of Y-box binding protein 1
(YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
Sci Rep. 7:20562017. View Article : Google Scholar : PubMed/NCBI
|
38
|
Ha B, Lee EB, Cui J, Kim Y and Jang HH:
YB-1 overexpression promotes a TGF-β1-induced
epithelial-mesenchymal transition via Akt activation. Biochem
Biophys Res Commun. 458:347–351. 2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Wu SL, Fu X, Huang J, Jia TT, Zong FY, Mu
SR, Zhu H, Yan Y, Qiu S, Wu Q, et al: Genome-wide analysis of
YB-1-RNA interactions reveals a novel role of YB-1 in miRNA
processing in glioblastoma multiforme. Nucleic Acids Res.
43:8516–8528. 2015. View Article : Google Scholar : PubMed/NCBI
|
40
|
Wei WJ, Mu SR, Heiner M, Fu X, Cao LJ,
Gong XF, Bindereif A and Hui J: YB-1 binds to CAUC motifs and
stimulates exon inclusion by enhancing the recruitment of U2AF to
weak polypyrimidine tracts. Nucleic Acids Res. 40:8622–8636. 2012.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Dolfini D and Mantovani R: Targeting the
Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y. Cell Death Differ.
20:676–685. 2013. View Article : Google Scholar : PubMed/NCBI
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Shurtleff MJ, Temoche-Diaz MM, Karfilis
KV, Ri S and Schekman R: Y-box protein 1 is required to sort
microRNAs into exosomes in cells and in a cell-free reaction.
Elife. 5:e192762016. View Article : Google Scholar : PubMed/NCBI
|
44
|
Peter A, Weigert C, Staiger H, Rittig K,
Cegan A, Lutz P, Machicao F, Häring HU and Schleicher E: Induction
of stearoyl-CoA desaturase protects human arterial endothelial
cells against lipotoxicity. Am J Physiol Endocrinol Metab.
295:E339–E349. 2008. View Article : Google Scholar : PubMed/NCBI
|
45
|
Yuan Z, Shin J, Wilson A, Goel S, Ling YH,
Ahmed N, Dopeso H, Jhawer M, Nasser S, Montagna C, et al: An A13
repeat within the 3-untranslated region of epidermal growth factor
receptor (EGFR) is frequently mutated in microsatellite instability
colon cancers and is associated with increased EGFR expression.
Cancer Res. 69:7811–7818. 2009. View Article : Google Scholar : PubMed/NCBI
|
46
|
Khan A, Fornes O, Stigliani A, Gheorghe M,
Castro-Mondragon JA, van der Lee R, Bessy A, Chèneby J, Kulkarni
SR, Tan G, et al: JASPAR 2018: Update of the open-access database
of transcription factor binding profiles and its web framework.
Nucleic Acids Res. 46:D260–D266. 2018. View Article : Google Scholar : PubMed/NCBI
|
47
|
Li J, Lu Y, Akbani R, Ju Z, Roebuck PL,
Liu W, Yang JY, Broom BM, Verhaak RGW, Kane DW, et al: TCPA: A
resource for cancer functional proteomics data. Nat Methods.
10:1046–1047. 2013. View Article : Google Scholar : PubMed/NCBI
|
48
|
Pisanu ME, Noto A, De Vitis C, Morrone S,
Scognamiglio G, Botti G, Venuta F, Diso D, Jakopin Z, Padula F, et
al: Blockade of Stearoyl-CoA-desaturase 1 activity reverts
resistance to cisplatin in lung cancer stem cells. Cancer Lett.
406:93–104. 2017. View Article : Google Scholar : PubMed/NCBI
|
49
|
Horikawa M, Nomura T, Hashimoto T and
Sakamoto K: Elongation and desaturation of fatty acids are critical
in growth, lipid metabolism and ontogeny of caenorhabditis elegans.
J Biochem. 144:149–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
50
|
von Roemeling CA, Marlow LA, Wei JJ,
Cooper SJ, Caulfield TR, Wu K, Tan WW, Tun HW and Copland JA:
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target
for clear cell renal cell carcinoma. Clin Cancer Res. 19:2368–2380.
2013. View Article : Google Scholar : PubMed/NCBI
|
51
|
Zhang H, Li H, Ho N, Li D and Li S: Scd1
plays a tumor-suppressive role in survival of leukemia stem cells
and the development of chronic myeloid leukemia. Mol Cell Biol.
32:1776–1787. 2012. View Article : Google Scholar : PubMed/NCBI
|